Crossref
S-palmitoylation in cancer: From molecular mechanisms to preclinical therapeutic opportunities
Cellular Signalling · 2026-11 · 113015
DOI: 10.1016/j.cellsig.2026.113015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026-11. Verfasst von Yu Ding und 2 weiteren Autor:innen. Die Arbeit nennt 133 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ding, Y., Deng, X., & Zhou, Y. (2026). S-palmitoylation in cancer: From molecular mechanisms to preclinical therapeutic opportunities. Cellular Signalling, 113015. https://doi.org/10.1016/j.cellsig.2026.113015
Vancouver
Ding Y, Deng X, Zhou Y. S-palmitoylation in cancer: From molecular mechanisms to preclinical therapeutic opportunities. Cellular Signalling. 2026:113015. doi:10.1016/j.cellsig.2026.113015
BibTeX
@article{Ding2026,
author = {Ding, Yu and Deng, Xiao-Hua and Zhou, Yi},
title = {S-palmitoylation in cancer: From molecular mechanisms to preclinical therapeutic opportunities},
journal = {Cellular Signalling},
year = {2026},
pages = {113015},
doi = {10.1016/j.cellsig.2026.113015}
}
EUVIMED